Curemark Competitors and Similar CompaniesClear all
Synthorx's competitors and similar companies include Incendia Therapeutics.
 Synthorx Synthorx is a biotechnology company using synthetic biology starting with its novel DNA base pair to discover and develop new protein therapeutics. |  Incendia Therapeutics Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment. | |
Founding Date | Founding Date 2014 | Founding Date 2019 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Boston, US HQ |
Employees | Employees 3939% increase | Employees 41 |
Funding | ||
Total funding raised | Total funding raised $ 79m | Total funding raised $ 65m |
For sources of this data, please see the company profile
View Company Profiles
Incendia Therapeutics
HQ
Boston, US
Employees
41
Incendia Therapeutics (formerly known as Parthenon Therapeutics) is a biotech company that develops anti-cancer therapies for reprogramming the tumor microenvironment.
View company